Examining retinal blood vessels in patients with common internal diseases using advanced imaging

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate retinal vascular changes in patients with hypertension, diabetes mellitus, and dyslipidemia using optical coherence tomography angiography (OCTA). The study will collect comprehensive patient data, including demographics, comorbidities, medications, and various laboratory tests over a follow-up period of five years. By utilizing OCTA, the researchers hope to quantify vascular changes in a noninvasive manner, providing valuable insights into the relationship between these common internal diseases and retinal health.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients with hypertension
* Or patients with diabetes
* Or patients with dyslipidemia
* Agree to participate in this study

Exclusion Criteria:

* Patients with malignant tumors
* Patients with autoimmune diseases
* Patients with immunodeficiency disease
* Disagree to participate in this study

Where it's running

• Beijing Tongren Hospital
  Beijing, Beijing Municipality, China Recruiting

Study contacts

• Study coordinator: Yu He, MD
• Email: bluelight323@126.com
• Phone: +861058268320

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Home-based cardiovascular health screening for people turning 50, 55, 60, 65, 70 or 75 in Uppsala

  This trial tests whether giving people a home blood pressure monitor, a dried blood spot kit, and a questionnaire can find more cardiovascular risk factors than usual care.

  Recruiting Uppsala University · Uppsala · NCT07614659

• Taining Golden Lake comprehensive chronic disease management program

  This project will build a large cohort of adults in Taining County to collect health data and try to create a county-level chronic disease management model for people with hypertension, diabetes, dyslipidemia, and other long-term conditions.

  Recruiting First Affiliated Hospital of Fujian Medical University · Fuzhou, Fujian · NCT07308314

• Linking social care with healthcare to help manage chronic diseases

  This trial tests whether pairing patients with trained community health workers can help them get transportation, healthy food, information, and better access to care to improve health in conditions like hypertension, diabetes, and high cholesterol.

  Recruiting at 2 sites University of Arizona · Tucson, Arizona and 1 other locations · NCT07799961

• Adapting and testing PEN-Plus in Zambian primary care

  Aiming to see if the PEN-Plus package can be adapted and used in two Zambian hospitals to better manage chronic diseases like heart disease, diabetes, hypertension, and sickle cell in primary care.

  Recruiting Centre for Infectious Disease Research in Zambia · Lusaka, Lusaka Province · NCT07753681

• Goal-commitment coaching to boost proactive health actions in adults with hypertension, diabetes, or high cholesterol

  This project will try a goal-commitment behavioral program to see if it helps adults with hypertension, diabetes, or high cholesterol adopt more proactive health habits.

  Recruiting Huazhong University of Science and Technology · Wuhan, Hubei · NCT07552571

• Environmental and inflammatory links to metabolic and endocrine diseases

  This project will see if combining environmental, genetic, and protein information can help predict early risk of diabetes, hypertension, and other metabolic or endocrine problems in community adults.

  Recruiting Chongqing Medical University · Chongqing · NCT07512609

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.